Market

Lilly moves obesity drug to late-stage trials after it shows promise

Lilly moves obesity drug to late-stage trials after it shows promise
Read More

Related Posts

German industrial orders rise more than expected in October

German industrial orders rise more than expected in Oct...

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Woodward director Sengstack sells $2.1m in shares

Woodward director Sengstack sells $2.1m in shares

DeNinno, Wabtec exec VP, sells $1.07 million in WAB stock

DeNinno, Wabtec exec VP, sells $1.07 million in WAB stock

Our Roth conversion triggered extra fees for Medicare premiums. Can I appeal?

Our Roth conversion triggered extra fees for Medicare p...

Inflation didn’t get any worse before the government shutdown. The Fed is expected to cut rates again.

Inflation didn’t get any worse before the government sh...